nickname: EMA21
url: https://www.ema.europa.eu/en/documents/referral/regn-cov2-antibody-combination-casirivimab/imdevimab-covid19-article-53-procedure-assessment-report_en.pdf
title: "Regeneron Ireland DAC use of casirivimab and imdevimab for the treatment of COVID-19"
journal: EMA
publisher: EMA
year: 2021
publish_date: "2021-02-25"
abstract: |-
  ([Full article](https://www.ema.europa.eu/en/documents/referral/regn-cov2-antibody-combination-casirivimab/imdevimab-covid19-article-53-procedure-assessment-report_en.pdf))
